Zobrazeno 1 - 10
of 108
pro vyhledávání: '"G C, Schito"'
Autor:
Teresita Mazzei, Juan Palou, G. C. Schito, L. Gualco, Anna Marchese, Kurt G. Naber, Henry Botto
Publikováno v:
Journal of Chemotherapy. 22:345-355
Because of increasing antibiotic resistance in Escherichia coli, the main uropathogen of uncomplicated urinary tract infections (UTIs), updated susceptibility data are vital in guiding the selection of first-line treatment agents. interpretation of t
Autor:
Roberto Mattina, Stefania Stefani, M.A. Tufano, Fabio Rossano, Giorgio Palù, Guido Fadda, G. C. Schito, Giuseppe Nicoletti, Maria Lina Mezzatesta
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
In this study we evaluated the in vitro activities of cefditoren--a broad-spectrum oral cephalosporin--and other comparator agents against 2,396 fresh isolates from community-acquired respiratory tract infections, collected from 6 clinical Italian mi
Publikováno v:
International Journal of Antimicrobial Agents. 31:321-328
The aim of this study was to assess whether the novel lipopeptide daptomycin might be capable of disrupting or inhibiting the synthesis of biofilms produced by staphylococci. Fourteen recently isolated slime-producing methicillin-susceptible (MET-S)
Publikováno v:
International Journal of Antimicrobial Agents. 30:415-421
The aim of this study was to assess whether moxifloxacin is able to inhibit the synthesis of and to disrupt biofilms produced in vitro by bacterial pathogens involved in acute bacterial exacerbations of chronic bronchitis. Three strains each of Haemo
Publikováno v:
Journal of Chemotherapy. 18:507-513
A total of 102 patients with recurrent upper respiratory tract infections underwent microbiological exploration with appropriate sampling and direct biopsies of the infected sites. Therapy was then started and on day 1 each patient received two intra
Autor:
G. C. Schito, M.H.J. Keenan
Publikováno v:
Journal of Chemotherapy. 17:33-40
Time above MIC (T>MIC) is regarded as the best pharmacokinetic/pharmacodynamic (PK/PD) parameter for predicting the clinical efficacy of cephalosporins. The concentration of non-protein-bound proprietary ceftriaxone (Rocephin, Roche) in body fluids e
Publikováno v:
Journal of Chemotherapy. 17:251-257
During 2004 four Italian Laboratories assessed the prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female out-patients. A total of 600 urine samples from individuals aged 18-65 were studied. The overa
Autor:
G. C. Schito
Publikováno v:
Journal of Chemotherapy. 16:19-34
(2004). Resistance Trends in Streptococcus pneumonia (PROTEKT Years 1-3 [1999-2002]) Journal of Chemotherapy: Vol. 16, Results from the First 3 Years (1999-2002) of PROTEKT, a Global Longitudinal Surveillance Study of Antimicrobial Resistance Among R
Publikováno v:
Journal of Chemotherapy. 16:13-22
The increase in resistance to macrolides has been linked with increasing use of these agents as empirical therapy for community-acquired respiratory tract infections (CARTIs). As part of the ongoing PROTEKT (Prospective Resistant Organism Tracking an
Autor:
Anna Maria Schito, G. C. Schito, E. Cercenado, Josefina Liñares, Emilio Bouza, Giovanni Russo, Eugenio A. Debbia
Publikováno v:
Europe PubMed Central
Antibacterial resistance was evaluated among Streptococcus pneumoniae (n=252) and Haemophilus influenzae (n=202) from two centres in Spain (Barcelona and Madrid) and two centres in Italy (Genoa and Catania) collected during 1999-2000 as part of the o